FPR1 and relapsing-remitting multiple sclerosis: Patients with relapsing-remitting multiple sclerosis (RRMS) have an increased number of neutrophils that regulated phenotypic changes such as reduction of apoptosis and higher expression of TLR2, FPR1, CXCR1, and CD43 [130].